Supplementation of naringenin and its synthetic derivative alters antioxidant enzyme activities of erythrocyte and liver in high cholesterol-fed rats

Cited 46 time in scopus
Metadata Downloads

Full metadata record

DC FieldValueLanguage
dc.contributor.authorMi Kyung Lee-
dc.contributor.authorSong Hae Bok-
dc.contributor.authorTae Sook Jeong-
dc.contributor.authorSurk Sik Moon-
dc.contributor.authorSeung Eun Lee-
dc.contributor.authorYong Bok Park-
dc.contributor.authorMyung Sook Choi-
dc.date.accessioned2017-04-19T08:58:59Z-
dc.date.available2017-04-19T08:58:59Z-
dc.date.issued2002-
dc.identifier.issn0968-0896-
dc.identifier.uri10.1016/S0968-0896(02)00059-7ko
dc.identifier.urihttps://oak.kribb.re.kr/handle/201005/5811-
dc.description.abstractThe antioxidative effects of naringenin (1) and its synthetic derivative, naringenin 7-O-cetyl ether (2), were tested. Male rats were fed a 1 g/100 g high-cholesterol diet for 6 weeks with supplements of either 1 or 2 (0.073 mmol/100 g diet) to study the effects on the antioxidant enzyme activities in the erythrocyte and liver. The erythrocyte catalase (CAT) and superoxide dismutase (SOD) activities were significantly higher in the compounds 1 or 2 supplemented groups than in the control group, whereas the hepatic SOD and CAT activities were significantly lower in the compound 2 supplemented group. The compounds 1 and 2 supplements to a high cholesterol diet lowered or tended to lower the plasma TBARS levels, that is, lipid peroxide products, while enhancing the plasma paraoxonase activity. These results indicate that the supplementation of 1 and 2 was effective in improving the antioxidant capacity of the erythrocyte and liver, plus the synthetic functional compound 2 appeared to be as potent as 1 in enhancing the antioxidant defense system.-
dc.publisherElsevier-
dc.titleSupplementation of naringenin and its synthetic derivative alters antioxidant enzyme activities of erythrocyte and liver in high cholesterol-fed rats-
dc.title.alternativeSupplementation of naringenin and its synthetic derivative alters antioxidant enzyme activities of erythrocyte and liver in high cholesterol-fed rats-
dc.typeArticle-
dc.citation.titleBioorganic & Medicinal Chemistry-
dc.citation.number7-
dc.citation.endPage2244-
dc.citation.startPage2239-
dc.citation.volume10-
dc.contributor.affiliatedAuthorSong Hae Bok-
dc.contributor.affiliatedAuthorTae Sook Jeong-
dc.contributor.alternativeName이미경-
dc.contributor.alternativeName복성해-
dc.contributor.alternativeName정태숙-
dc.contributor.alternativeName문석식-
dc.contributor.alternativeName이승은-
dc.contributor.alternativeName박용복-
dc.contributor.alternativeName최명숙-
dc.identifier.bibliographicCitationBioorganic & Medicinal Chemistry, vol. 10, no. 7, pp. 2239-2244-
dc.identifier.doi10.1016/S0968-0896(02)00059-7-
dc.description.journalClassY-
Appears in Collections:
Division of A.I. & Biomedical Research > Microbiome Convergence Research Center > 1. Journal Articles
Files in This Item:
  • There are no files associated with this item.


Items in OpenAccess@KRIBB are protected by copyright, with all rights reserved, unless otherwise indicated.